Dr. Faramarz H. Samie, MD

Dr. Samie practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Samie's NPI, 1982646782, was assigned on June 13, 2006. Dr. Samie graduated from SUNY Upstate Medical University in 2002. Dr. Samie's New York license number on file is 239725.

Dr. Samie's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Samie's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Samie is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Samie to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samie practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Samie's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Samie is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Samie's licenses on file in 3 states: New York, New Hampshire and Pennsylvania.

CMS data shows 1,851 Medicare services from Dr. Samie across 24 procedure codes in 2024, for 512 Medicare patients. Medicare paid $459,756 for them. Every service was in an office.

CMS counts 512 Medicare patients who saw Dr. Samie in 2024. The largest group is 75 to 84, with 239 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Samie's median patient age at 69, with 43% women.

In 2024, Dr. Samie wrote 90 Medicare Part D claims for 66 patients. 84% of them were for generic drugs. CMS names the drug for 55 of them, across 3 drugs with 11 or more claims each, at $2,111 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Samie for performance year 2024, reported through an alternative payment model (APM). Dr. Samie accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Samie as offering telehealth. CMS counts 161 procedures of melanoma (skin cancer) excision by Dr. Samie, more than 96% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 107 papers to Dr. Samie, published from 2008 to 2025. 2020 was the busiest year, with 17. The most frequent topics are Skin Neoplasms, Mohs Surgery and Carcinoma, Squamous Cell. Dr. Samie has published most often in Dermatol Surg. Dr. Samie's most frequent co-authors are Megan Hannah Trager, Dawn Suisun Queen, MD and Jesse Miller Lewin, MD.

Dmand AI lists 2 awards for Dr. Samie, most recently CMS Stage 1 EHR in 2013.

Dr. Samie graduated from SUNY Upstate Medical University in 2002. Dr. Samie is a member of AAD.

Dr. Samie is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.